PubMed

Perspective: Medical school admissions and noncognitive testing: some open questions.

Bardes CL, Best PC, Kremer SJ, Dienstag JL.

Acad Med. 2009 Oct;84(10):1360-3.PMID: 19881422 [PubMed - indexed for MEDLINE]Related articles

Des-gamma-Carboxy Prothrombin and alpha-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma.

Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky HL, Dienstag JL; HALT-C Trial Group.

Gastroenterology. 2009 Oct 20. [Epub ahead of print]PMID: 19852963 [PubMed - as supplied by publisher]Related articles

Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.

Goodman ZD, Stoddard AM, Bonkovsky HL, Fontana RJ, Ghany MG, Morgan TR, Wright EC, Brunt EM, Kleiner DE, Shiffman ML, Everson GT, Lindsay KL, Dienstag JL, Morishima C; HALT-C Trial Group.

Hepatology. 2009 Dec;50(6):1738-49.PMID: 19824074 [PubMed - indexed for MEDLINE]Related articles

Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C.

Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL; HALT-C Trial Group.

Gastroenterology. 2009 Sep 18. [Epub ahead of print]PMID: 19766643 [PubMed - as supplied by publisher]Related articles

Effect of HCV RNA suppression during peginterferon Alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.

Shiffman ML, Morishima C, Dienstag JL, Lindsay KL, Hoefs JC, Lee WM, Wright EC, Naishadham D, Everson GT, Lok AS, Di Bisceglie AM, Bonkovsky HL, Ghany MG; HALT-C Trial Group.

Gastroenterology. 2009 Dec;137(6):1986-94. Epub 2009 Sep 10.PMID: 19747918 [PubMed - in process]Related articles

Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers.

Corey KE, Servoss JC, Casson DR, Kim AY, Robbins GK, Franzini J, Twitchell K, Loomis SC, Abraczinskas DR, Terella AM, Dienstag JL, Chung RT.

Infect Control Hosp Epidemiol. 2009 Oct;30(10):1000-5.PMID: 19743901 [PubMed - indexed for MEDLINE]Related articles

Commentary: Assessment is an educational tool.

Krupat E, Dienstag JL.

Acad Med. 2009 May;84(5):548-50.PMID: 19704183 [PubMed - indexed for MEDLINE]Related articles

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R; HALT-C Trial Group.

Hepatology. 2009 Nov;50(5):1360-9.PMID: 19676128 [PubMed - indexed for MEDLINE]Related articles

Benefits and risks of nucleoside analog therapy for hepatitis B.

Dienstag JL.

Hepatology. 2009 May;49(5 Suppl):S112-21.PMID: 19399795 [PubMed - indexed for MEDLINE]Related articles

Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.

Fontana RJ, Bonkovsky HL, Naishadham D, Dienstag JL, Sterling RK, Lok AS, Su GL; Halt-C Trial Group.

Clin Gastroenterol Hepatol. 2009 Feb;7(2):219-26. Epub 2008 Nov 7.PMID: 19068241 [PubMed - indexed for MEDLINE]Related articles

Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL; HALT-C Trial Investigators.

N Engl J Med. 2008 Dec 4;359(23):2429-41.PMID: 19052125 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD; HALT-C Trial Group.

Gastroenterology. 2009 Jan;136(1):138-48. Epub 2008 Sep 18.PMID: 18848939 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B virus infection.

Dienstag JL.

N Engl J Med. 2008 Oct 2;359(14):1486-500. Review. No abstract available. PMID: 18832247 [PubMed - indexed for MEDLINE]Related articles

Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C.

Morishima C, Morgan TR, Everhart JE, Wright EC, Apodaca MC, Gretch DR, Shiffman ML, Everson GT, Lindsay KL, Lee WM, Lok AS, Dienstag JL, Ghany MG, Curto TM; HALT-C Trial Group.

Hepatology. 2008 Nov;48(5):1412-9.PMID: 18816437 [PubMed - indexed for MEDLINE]Related articles

Relevance and rigor in premedical education.

Dienstag JL.

N Engl J Med. 2008 Jul 17;359(3):221-4. No abstract available. PMID: 18635426 [PubMed - indexed for MEDLINE]Related articles

Hepatitis A: the vaccine dividend.

Dienstag JL.

J Infect Dis. 2008 May 1;197(9):1220-2. No abstract available. PMID: 18422432 [PubMed - indexed for MEDLINE]Related articles

Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.

Lindsay KL, Morishima C, Wright EC, Dienstag JL, Shiffman ML, Everson GT, Lok AS, Bonkovsky HL, Lee WM, Morgan TR, Ghany MG; HALT-C Trial.

Clin Gastroenterol Hepatol. 2008 Feb;6(2):234-41.PMID: 18237873 [PubMed - indexed for MEDLINE]Related articles

Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.

Reddy KR, Govindarajan S, Marcellin P, Bernstein D, Dienstag JL, Bodenheimer H Jr, Rakela J, Messinger D, Schmidt G, Ackrill A, Hadziyannis SJ.

J Viral Hepat. 2008 Feb;15(2):129-36.PMID: 18184196 [PubMed - indexed for MEDLINE]Related articles

Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.

Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky HL, Naishadham D, Sterling RK, Su GL, Ghosh M, Wright EC; HALT-C Trial Group.

Hepatology. 2008 Mar;47(3):789-98.PMID: 18175357 [PubMed - indexed for MEDLINE]Related articles

Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.

Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, Shiffman ML, Lindsay KL, Lok AS, Di Bisceglie AM, Lee WM, Ghany MG; HALT-C Trial Group.

Hepatology. 2008 Feb;47(2):605-12.PMID: 18157835 [PubMed - indexed for MEDLINE]Related articles

Oral antivirals for chronic hepatitis B.

Min AD, Dienstag JL.

Clin Liver Dis. 2007 Nov;11(4):851-68, ix. Review.PMID: 17981232 [PubMed - indexed for MEDLINE]Related articles

Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.

Shiffman ML, Ghany MG, Morgan TR, Wright EC, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Gretch DR.

Gastroenterology. 2007 Jan;132(1):103-12. Epub 2006 Nov 11.PMID: 17241864 [PubMed - indexed for MEDLINE]Related articles

Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy.

Bourne EJ, Dienstag JL, Lopez VA, Sander TJ, Longlet JM, Hall JG, Kwiatkowski RW, Wright T, Lai CL, Condreay LD.

J Viral Hepat. 2007 Jan;14(1):55-63.PMID: 17212645 [PubMed - indexed for MEDLINE]Related articles

Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.

Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR; HALT-C Trial Group.

J Hepatol. 2007 Mar;46(3):420-31. Epub 2006 Nov 27.PMID: 17196293 [PubMed - indexed for MEDLINE]Related articlesFree article

Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients.

Dienstag JL, Wei LJ, Xu D, Kreter B.

Clin Drug Investig. 2007;27(1):35-49. Review.PMID: 17177578 [PubMed - indexed for MEDLINE]Related articles

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.

Everson GT, Hoefs JC, Seeff LB, Bonkovsky HL, Naishadham D, Shiffman ML, Kahn JA, Lok AS, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Morishima C; HALT-C Trial Group.

Hepatology. 2006 Dec;44(6):1675-84.PMID: 17133499 [PubMed - indexed for MEDLINE]Related articles

HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.

Morishima C, Morgan TR, Everhart JE, Wright EC, Shiffman ML, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Gretch DR; HALT-C Trial Group.

Hepatology. 2006 Aug;44(2):360-7.PMID: 16871570 [PubMed - indexed for MEDLINE]Related articles

Hepatitis C: a bitter harvest.

Dienstag JL.

Ann Intern Med. 2006 May 16;144(10):770-1. No abstract available. PMID: 16702593 [PubMed - indexed for MEDLINE]Related articlesFree article

Advancing patient care: integrating new data.

Wright TL, Avunduk C, Dienstag JL, Freston JW, Jacobson IM, Nord HJ, Sherman M.

Am J Gastroenterol. 2006;101 Suppl 1:S32-9. Review.PMID: 16448450 [PubMed - indexed for MEDLINE]Related articles

Looking to the future: new agents for chronic hepatitis B.

Dienstag JL.

Am J Gastroenterol. 2006;101 Suppl 1:S19-25. Review.PMID: 16448448 [PubMed - indexed for MEDLINE]Related articles

American Gastroenterological Association technical review on the management of hepatitis C.

Dienstag JL, McHutchison JG.

Gastroenterology. 2006 Jan;130(1):231-64; quiz 214-7. Review. No abstract available. PMID: 16401486 [PubMed - indexed for MEDLINE]Related articles

American Gastroenterological Association medical position statement on the management of hepatitis C.

Dienstag JL, McHutchison JG.

Gastroenterology. 2006 Jan;130(1):225-30. No abstract available. Erratum in: Gastroenterology. 2006 Mar;130(3):1018. Gastroenterology. 2006 Sep;131(3):979. PMID: 16401485 [PubMed - indexed for MEDLINE]Related articles

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DR; HALT-C Trial Group.

J Hepatol. 2005 Sep;43(3):434-41.PMID: 16136646 [PubMed - indexed for MEDLINE]Related articles

Hepatitis A--the price of progress.

Di Giammarino L, Dienstag JL.

N Engl J Med. 2005 Sep 1;353(9):944-6. No abstract available. PMID: 16135841 [PubMed - indexed for MEDLINE]Related articles

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C.

Hepatology. 2005 Aug;42(2):282-92.PMID: 15986415 [PubMed - indexed for MEDLINE]Related articles

The value and limitations of long-term nucleoside antiviral therapy in chronic hepatitis B.

Dienstag JL.

J Hepatol. 2005 Feb;42(2):158-62. Review. No abstract available. PMID: 15664237 [PubMed - indexed for MEDLINE]Related articles

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

Lee WM, Dienstag JL, Lindsay KL, Lok AS, Bonkovsky HL, Shiffman ML, Everson GT, Di Bisceglie AM, Morgan TR, Ghany MG, Morishima C, Wright EC, Everhart JE; HALT-C Trial Group.

Control Clin Trials. 2004 Oct;25(5):472-92.PMID: 15465617 [PubMed - indexed for MEDLINE]Related articles

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

Shiffman ML, Di Bisceglie AM, Lindsay KL, Morishima C, Wright EC, Everson GT, Lok AS, Morgan TR, Bonkovsky HL, Lee WM, Dienstag JL, Ghany MG, Goodman ZD, Everhart JE; Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group.

Gastroenterology. 2004 Apr;126(4):1015-23; discussion 947.PMID: 15057741 [PubMed - indexed for MEDLINE]Related articles

Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B.

Kuo A, Dienstag JL, Chung RT.

Clin Gastroenterol Hepatol. 2004 Mar;2(3):266-72.PMID: 15017612 [PubMed - indexed for MEDLINE]Related articles

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

Lok AS, Lai CL, Leung N, Yao GB, Cui ZY, Schiff ER, Dienstag JL, Heathcote EJ, Little NR, Griffiths DA, Gardner SD, Castiglia M.

Gastroenterology. 2003 Dec;125(6):1714-22.PMID: 14724824 [PubMed - indexed for MEDLINE]Related articles

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.

Schiff ER, Dienstag JL, Karayalcin S, Grimm IS, Perrillo RP, Husa P, de Man RA, Goodman Z, Condreay LD, Crowther LM, Woessner MA, McPhillips PJ, Brown NA; International Lamivudine Investigator Group.

J Hepatol. 2003 Jun;38(6):818-26.PMID: 12763376 [PubMed - indexed for MEDLINE]Related articles

Durability of serologic response after lamivudine treatment of chronic hepatitis B.

Dienstag JL, Cianciara J, Karayalcin S, Kowdley KV, Willems B, Plisek S, Woessner M, Gardner S, Schiff E.

Hepatology. 2003 Apr;37(4):748-55.PMID: 12668966 [PubMed - indexed for MEDLINE]Related articles

Histological outcome during long-term lamivudine therapy.

Dienstag JL, Goldin RD, Heathcote EJ, Hann HW, Woessner M, Stephenson SL, Gardner S, Gray DF, Schiff ER.

Gastroenterology. 2003 Jan;124(1):105-17.PMID: 12512035 [PubMed - indexed for MEDLINE]Related articles

The role of liver biopsy in chronic hepatitis C.

Dienstag JL.

Hepatology. 2002 Nov;36(5 Suppl 1):S152-60. Review.PMID: 12407589 [PubMed - indexed for MEDLINE]Related articles

Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.

Perrillo RP, Lai CL, Liaw YF, Dienstag JL, Schiff ER, Schalm SW, Heathcote EJ, Brown NA, Atkins M, Woessner M, Gardner SD.

Hepatology. 2002 Jul;36(1):186-94.PMID: 12085364 [PubMed - indexed for MEDLINE]Related articles

Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin.

McHutchison JG, Poynard T, Esteban-Mur R, Davis GL, Goodman ZD, Harvey J, Ling MH, Garaud JJ, Albrecht JK, Patel K, Dienstag JL, Morgan T; International Hepatitis Interventional Therapy Group.

Hepatology. 2002 Mar;35(3):688-93. Erratum in: Hepatology 2002 Aug;36(2):519. PMID: 11870385 [PubMed - indexed for MEDLINE]Related articles

Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.

Rosenberg PM, Farrell JJ, Abraczinskas DR, Graeme-Cook FM, Dienstag JL, Chung RT.

Am J Gastroenterol. 2002 Feb;97(2):478-83.PMID: 11866292 [PubMed - indexed for MEDLINE]Related articles

Non-A, non-B hepatitis. 1976.

Purcell RH, Alter HJ, Dienstag JL.

Yale J Biol Med. 2000 Jan-Dec;73(1-6):175-82. No abstract available. PMID: 11765936 [PubMed - indexed for MEDLINE]Related articles

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

Kweon YO, Goodman ZD, Dienstag JL, Schiff ER, Brown NA, Burchardt E, Schoonhoven R, Brenner DA, Fried MW.

J Hepatol. 2001 Dec;35(6):749-55. Erratum in: J Hepatol 2002 May;36(5):714. Burkhardt ER [corrected to Burchardt ER]. PMID: 11738102 [PubMed - indexed for MEDLINE]Related articles

Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.

McHutchison JG, Shad JA, Gordon SC, Morgan TR, Ling MH, Garaud JJ, Albrecht JK, Dienstag JL.

J Viral Hepat. 2001 Nov;8(6):414-20.PMID: 11703572 [PubMed - indexed for MEDLINE]Related articles